These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38585292)

  • 1. Machine Learning Model Based on the Neutrophil-to-Eosinophil Ratio Predicts the Recurrence of Hepatocellular Carcinoma After Surgery.
    Shao G; Ma Y; Qu C; Gao R; Zhu C; Qu L; Liu K; Li N; Sun P; Cao J
    J Hepatocell Carcinoma; 2024; 11():679-691. PubMed ID: 38585292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application value of machine learning algorithms for predicting recurrence after resection of early-stage hepatocellular carcinoma].
    Ji GW; Wang K; Xia YX; Li XC; Wang XH
    Zhonghua Wai Ke Za Zhi; 2021 Aug; 59(8):679-685. PubMed ID: 34192861
    [No Abstract]   [Full Text] [Related]  

  • 3. Nomograms Incorporating the CNLC Staging System Predict the Outcome of Hepatocellular Carcinoma After Curative Resection.
    Liao R; Wei XF; Che P; Yin KL; Liu L
    Front Oncol; 2021; 11():755920. PubMed ID: 35127471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a machine learning model to predict early recurrence for hepatocellular carcinoma after curative resection.
    Zeng J; Zeng J; Lin K; Lin H; Wu Q; Guo P; Zhou W; Liu J
    Hepatobiliary Surg Nutr; 2022 Apr; 11(2):176-187. PubMed ID: 35464276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction model for hepatocellular carcinoma recurrence after hepatectomy: Machine learning-based development and interpretation study.
    Liu R; Wu S; Yu HY; Zeng K; Liang Z; Li S; Hu Y; Yang Y; Ye L
    Heliyon; 2023 Nov; 9(11):e22458. PubMed ID: 38034691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival.
    Ma L; Deng K; Zhang C; Li H; Luo Y; Yang Y; Li C; Li X; Geng Z; Xie C
    Front Oncol; 2022; 12():843589. PubMed ID: 35296018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a machine learning-based model for predicting risk of early postoperative recurrence of hepatocellular carcinoma.
    Zhang YB; Yang G; Bu Y; Lei P; Zhang W; Zhang DY
    World J Gastroenterol; 2023 Nov; 29(43):5804-5817. PubMed ID: 38074914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Impact of Baseline Neutrophil-to-Eosinophil Ratio in Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab Therapy in Second or Later Lines.
    Gil L; Alves FR; Silva D; Fernandes I; Fontes-Sousa M; Alves M; Papoila A; Da Luz R
    Cureus; 2022 Feb; 14(2):e22224. PubMed ID: 35340486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning-based development and validation of a scoring system for progression-free survival in liver cancer.
    Liu X; Hou Y; Wang X; Yu L; Wang X; Jiang L; Yang Z
    Hepatol Int; 2020 Jul; 14(4):567-576. PubMed ID: 32556865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.
    Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
    EBioMedicine; 2019 Dec; 50():156-165. PubMed ID: 31735556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of Hepatocellular Carcinoma Patients with High Risk of Early Recurrence After Radical Hepatectomy Using a Nomogram Model Based on the γ-Glutamyl Transpeptidase-to-Albumin Ratio.
    Pang S; Shi Y; Xu D; Sun Z; Chen Y; Yang Y; Zhao X; Si-Ma H; Yang N
    J Gastrointest Surg; 2022 Aug; 26(8):1-9. PubMed ID: 35508683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.
    Ruan DY; Lin ZX; Li Y; Jiang N; Li X; Wu DH; Wang TT; Chen J; Lin Q; Wu XY
    World J Gastroenterol; 2015 May; 21(18):5598-606. PubMed ID: 25987785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of preoperative and postoperative machine learning models to predict the recurrence of huge hepatocellular carcinoma following surgical resection.
    Zhang Q; Fang G; Huang T; Wei G; Li H; Liu J
    Oncol Lett; 2023 Jul; 26(1):275. PubMed ID: 37274474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram Based on Inflammatory Biomarkers to Predict the Recurrence of Hepatocellular Carcinoma-A Multicentre Experience.
    Zheng Z; Guan R; Zou Y; Jian Z; Lin Y; Guo R; Jin H
    J Inflamm Res; 2022; 15():5089-5102. PubMed ID: 36091335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil-to-lymphocyte ratio and monocyte-to-eosinophil ratio as prognostic indicators for advanced nasopharyngeal carcinoma.
    Ye M; Huang A; Yuan B; Tan G; Ai J; Liu H
    Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):1971-1989. PubMed ID: 38315178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of machine learning models for predicting prognosis and guiding individualized postoperative chemotherapy: A real-world study of distal cholangiocarcinoma.
    Wang D; Pan B; Huang JC; Chen Q; Cui SP; Lang R; Lyu SC
    Front Oncol; 2023; 13():1106029. PubMed ID: 37007095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection.
    Wang J; Chen Z; Wang L; Feng S; Qiu Q; Chen D; Li N; Xiao Y
    Sci Rep; 2022 May; 12(1):8670. PubMed ID: 35606395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Machine Learning Models to Predict Recurrence After Surgical Resection of Nonmetastatic Renal Cell Carcinoma.
    Khene ZE; Bigot P; Doumerc N; Ouzaid I; Boissier R; Nouhaud FX; Albiges L; Bernhard JC; Ingels A; Borchiellini D; Kammerer-Jacquet S; Rioux-Leclercq N; Roupret M; Acosta O; De Crevoisier R; Bensalah K;
    Eur Urol Oncol; 2023 Jun; 6(3):323-330. PubMed ID: 35987730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A radiomics-based model can predict recurrence-free survival of hepatocellular carcinoma after curative ablation.
    Peng W; Jiang X; Zhang W; Hu J; Zhang Y; Zhang L
    Asian J Surg; 2023 Jul; 46(7):2689-2696. PubMed ID: 36351862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.